Ireland’s Call for KALYDECO
Ireland has the highest incidence of Cystic Fibrosis in the world. Ireland
also has the highest proportion of people with Cystic Fibrosis with the G551D
(the so called ‘celtic’) gene mutation in the world.
KALYDECO has already been approved by the medicines/drugs agencies in the
US and the EU and is the first ever drug available that impacts on
the underlying cause of Cystic Fibrosis for people that carry this gene
mutation (around 10% of people with CF in Ireland).
Because of huge research and development costs, there is no doubt that
this drug will be expensive, however there is strong evidence to support the
significant impact that this drug has had on patients, including CF patients in
Ireland who took part in the clinical trials and who are still being prescribed
with KALYDECO.
In Ireland it is vital that a fair arrangement is reached as soon as possible
between the HSE and Vertex, the drug's manufacturers, to ensure that this drug is
made available in Ireland for everyone who needs it.
Support CF treatment in Ireland. Support access to KALYDECO.
Sign this petition and help Ireland’s Call for Kalydeco.
Issued by the Cystic Fibrosis Association of Ireland.
Praying for everyone fighting for this. We need this drug in Ireland now.